WASHINGTON, DC – Energy and Commerce Republican Leader Greg Walden (R-OR) took to the House floor to call on lawmakers to reject Speaker Pelosi’s partisan drug pricing scheme, which will stifle innovation and lead to fewer cures for Americans desperately in need.
Walden made clear that H.R. 3 is offering a false choice to the American people: lower drug costs or more cures. Instead, Walden offered an alternative – the Lower Costs, More Cures Act (H.R. 19) – to lower drug costs for Americans without limiting access to cures.
Here’s What Walden Said:
WATCH WALDEN’S REMARKS ➡ “Is it ‘worth it’ to never have a cure for Alzheimer’s?”
“The Congressional Budget Office found Speaker Pelosi’s HR 3 would kill off at more than 38 new medical innovation. The Council of Economic Advisers said more than 100 new medicines would be lost. It’s no wonder that President Trump, the country’s strongest advocate for lowering drug prices said even he couldn’t support HR 3 and would have to veto it. Democrats ignore these facts. Some have even said it’s ‘worth it’ to forgo cures. Seriously? Is it ‘worth it’ to never have a cure for Alzheimer’s? Is it ‘worth it’ to never have a cure for ALS? What about Huntington’s disease, or Parkinson’s disease? The answer is no – because one lost cure is one too many,” said Walden.
Walden breaks down why H.R. 3 will stifle innovation and lead to fewer cures. CLICK HERE to watch Walden’s remarks.
WATCH WALDEN’S REMARKS ➡ “We can do this better. We can work together.”
“Democrats have said it’s ‘worth it’ not to have future cures. The Congressional Budget Office tells us up to 38 cures will not come about because of H.R. 3. Democrats have said they want to model America after foreign countries, and the facts show that foreign countries have access to fewer lifesaving drugs for cancer, diabetes, respiratory issues, and cardiovascular issues. The chart on the far side lists those drugs individually. We’re not making this up; this is fact. We can do this better. We can work together. But if you want to restrict access to drugs, or if you want to deny new cures to patients, or if you want to go on a system where you die because the medicine you need is not available in your country, then vote for H.R. 3. If you don’t, if you want to have lower drug prices, stop the gaming by the pharmaceutical companies, and have more cures, then support our alternative,” said Walden.
WATCH WALDEN’S REMARKS ➡ “I’m always willing to come to the other side of the aisle to work these things out.”
“Madame Speaker, I want to make clear that I am always willing to come to the other side of the aisle to work these things out. All of us came here with similar cause and calling, to lower the costs of prescription drugs. To stop the abuse and bad behavior of pharmaceutical companies when they keep generics from coming to market. But I don’t think anyone came here to take cures away from patients who come to our offices every year begging for a cure for Alzheimer’s, or pancreatic cancer, or ALS, you name the disease. We all want cures. We know by independent analysis that H.R. 3 denies access to cures. That is a fact. It is a fact that the Council of Economic Advisers said up to 100 cures will be lost. the Congressional Budget Office says in the next two decades 38 cures would be lost. It doesn’t have to be this way. We can lower drug costs. We can incent innovation. We have a letter from 138 leaders of these incredible American innovators who beg us not to shatter the dreams of Americans, which they say H.R. 3 will do by completely upending the process. That’s why President Trump said he cannot sign this. No president has ever leaned farther than President Trump to try to bring down drug prices. We have an alternative. Everything in our substitute is bipartisan. There’s no reason you should have to vote against the proposals in here. There’s not a poison pill, they are all bipartisan. They will all bring meaningful relief to our folks at home, and nothing in here will reduce innovation,” said Walden.
Walden literally crosses the aisle to urge for bipartisan support for the Lower Costs, More Cures Act. CLICK HERE to watch Walden’s remarks.
WATCH WALDEN’S REMARKS ➡ “A true consensus product, the Lower Costs, More Cures Act”
“There is a better way. We can reduce the high costs of drugs, improve health, and lower long-term costs without stifling innovation and restricting patients’ access to life-saving medications. A true consensus product, the Lower Costs, More Cures Act contains policies that track with much of the legislation that our colleagues in Senate Finance and HELP committees have been working on. H.R. 19 could be just the beginning – Republicans stand ready to work together with Democrats and are willing to collaborate on more bipartisan policies to lower prescription drug prices for consumers and we can do that without stealing the hope of new cures. We remain committed to doing that, if Democrats will come to the table, instead of trying to score political points. I urge my colleagues to reject Speaker Pelosi’s partisan plan, and vote yes on the bipartisan substitute, the Lower Costs, More Cures Act,” said Walden.